Literature DB >> 29790900

GSCALite: a web server for gene set cancer analysis.

Chun-Jie Liu1, Fei-Fei Hu1, Meng-Xuan Xia1, Leng Han2, Qiong Zhang1, An-Yuan Guo1.   

Abstract

Summary: The availability of cancer genomic data makes it possible to analyze genes related to cancer. Cancer is usually the result of a set of genes and the signal of a single gene could be covered by background noise. Here, we present a web server named Gene Set Cancer Analysis (GSCALite) to analyze a set of genes in cancers with the following functional modules. (i) Differential expression in tumor versus normal, and the survival analysis; (ii) Genomic variations and their survival analysis; (iii) Gene expression associated cancer pathway activity; (iv) miRNA regulatory network for genes; (v) Drug sensitivity for genes; (vi) Normal tissue expression and eQTL for genes. GSCALite is a user-friendly web server for dynamic analysis and visualization of gene set in cancer and drug sensitivity correlation, which will be of broad utilities to cancer researchers. Availability and implementation: GSCALite is available on http://bioinfo.life.hust.edu.cn/web/GSCALite/. Supplementary information: Supplementary data are available at Bioinformatics online.

Entities:  

Mesh:

Year:  2018        PMID: 29790900     DOI: 10.1093/bioinformatics/bty411

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  240 in total

1.  Identification of Circular RNA-Based Immunomodulatory Networks in Colorectal Cancer.

Authors:  Zongfeng Feng; Leyan Li; Yi Tu; Xufeng Shu; Yang Zhang; Qingwen Zeng; Lianghua Luo; Ahao Wu; Wenzheng Chen; Yi Cao; Zhengrong Li
Journal:  Front Oncol       Date:  2022-01-27       Impact factor: 6.244

2.  ERCC6L is a biomarker and therapeutic target for non-small cell lung adenocarcinoma.

Authors:  Guoxin Hou; Zhimin Lu; Yanyu Bi; Jingjing Deng; Xinmei Yang
Journal:  Med Oncol       Date:  2022-02-12       Impact factor: 3.064

3.  Integrative Analysis of Neuregulin Family Members-Related Tumor Microenvironment for Predicting the Prognosis in Gliomas.

Authors:  Wei-Jiang Zhao; Guan-Yong Ou; Wen-Wen Lin
Journal:  Front Immunol       Date:  2021-05-13       Impact factor: 7.561

4.  Development of a CAFs-related gene signature to predict survival and drug response in bladder cancer.

Authors:  Zhao Zhang; Zhijuan Liang; Dan Li; Liping Wang; Yuanbin Chen; Ye Liang; Wei Jiao; Haitao Niu
Journal:  Hum Cell       Date:  2022-01-19       Impact factor: 4.174

5.  ADORA1 is a diagnostic-related biomarker and correlated with immune infiltrates in papillary thyroid carcinoma.

Authors:  Xu Lin; Zhi-Yong Wang; Gang Xue; Xiao-Jing Qin; Jing-Fang Wu; Geng Zhang
Journal:  J Cancer       Date:  2021-05-13       Impact factor: 4.207

6.  MIR29A Impedes Metastatic Behaviors in Hepatocellular Carcinoma via Targeting LOX, LOXL2, and VEGFA.

Authors:  Ya-Ling Yang; Ming-Chao Tsai; Yen-Hsiang Chang; Chen-Chen Wang; Pei-Yi Chu; Hung-Yu Lin; Ying-Hsien Huang
Journal:  Int J Mol Sci       Date:  2021-06-01       Impact factor: 5.923

7.  Establishment of a Prognostic Model for Hepatocellular Carcinoma Based on Endoplasmic Reticulum Stress-Related Gene Analysis.

Authors:  Peng Liu; Jinhong Wei; Feiyu Mao; Zechang Xin; Heng Duan; Yan Du; Xiaodong Wang; Zhennan Li; Jianjun Qian; Jie Yao
Journal:  Front Oncol       Date:  2021-05-21       Impact factor: 6.244

8.  PLAU Promotes Cell Proliferation and Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma.

Authors:  Guangjin Chen; Jiwei Sun; Mengru Xie; Shaoling Yu; Qingming Tang; Lili Chen
Journal:  Front Genet       Date:  2021-05-20       Impact factor: 4.599

9.  Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for lung adenocarcinoma.

Authors:  Lei Gao; Ling Zhang
Journal:  BMC Cancer       Date:  2021-07-23       Impact factor: 4.430

10.  Early B-cell factors involve in the tumorigenesis and predict the overall survival of gastric cancer.

Authors:  Qing Wang; Jiahong Liang; Xianyu Hu; Songgang Gu; Qiaodong Xu; Jiang Yan
Journal:  Biosci Rep       Date:  2021-07-30       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.